3/18/2024CDE Publicizes the List of Reference Formulations for GQCE Studies (80...

3/18/2024The US and Chinese Biopharma Contractors (Science)

3/15/2024Major Life Sciences Licensing Deal Trends in China in 2023 (Supra)

3/15/2024Chinese Pharma Stocks Surge amid Speculation of Government Support for...

3/15/2024Biotheus and Hansoh Pharma Expand ADC Collaboration

3/15/2024Unveiling Quality of Clinical Trial in China: from Concern to Confirma...

3/15/2024Recent Executive Moves

3/15/2024Drug R&D and Product Registration News Digest March 2024 (2)

3/14/2024Sinohealth: Review of Chinese Retail Pharmacy Drug Sales and Top 20 Pr...

3/14/2024PhIIC: Review of Prescription Drug Sales Trends in Chinese Retail Phar...

3/13/2024IQVIA: Chinese Hospital Drug Market Rose 4.2% in 2023 (MAT Q4/2023)

3/13/2024Biotech Lobby Group BIO to Sever Ties with WuXi Amid National Security...

3/13/2024WuXi Became a Critical Partner to Biopharma Companies. They're Not Rea...

3/13/2024Navigating China's Biologics Approval And Accelerated Pathways (Clinic...

3/12/2024Global Pharmaceutical Investment in Asia: A Strategic Focus Amidst Evo...

3/12/2024CDE Issues the List of Reference Formulations for GQCE Studies (78th B...

3/12/2024BIO Faces Criticism for Involvement in Legislation Concerning China's ...

3/11/2024Johnson & Johnson Completes Acquisition of Ambrx

3/11/2024Startups Raised Millions to In-license Drugs to China. Then the Model ...

3/10/2024China Biopharma Tracker – February 2024 (PharmaNJ)

3/8/2024BeiGene Still Bleeding Red Ink Despite Blockbuster Drug (Bamboo Works)

3/8/2024Recent Official Changes and Executive Moves

3/8/2024Drug R&D and Product Registration News Digest March 2024 (1)

3/7/2024Novo Nordisk Expects Chinese Approval for Weight Loss Drug Wegovy This...

3/7/2024Lessons from China's 2023 National Negotiation of Drug Prices (NLR)

3/7/2024Time To 'Cut Off' US Outbound Investment in China Biotech Firms Like B...

3/6/2024Weight Loss Drugs Threatened by US Effort to Contain China (Bloomberg)

3/6/2024CDE's Annual Review of Chinese Drug Evaluation and Registration in 202...

3/6/2024US Senate Committee Approves Bill That Could Restrict Chinese Biotech

3/6/2024Biopharma Delegates Advocate for Policy Reforms During China's Two Ses...

Page:7/711 Total number of articles:21317: [First][<<] [5] [6] [7] [8] [9] [>>] [End]